Developer docs
API playgroundTry for free, no card

Search company profiles

Advanced Biologics

Full company profile

uuid000pdcy

Namestring
Advanced Biologics
Legal namestring
Isto Biologics
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Advanced Biologics operates as Isto Biologics, a privately held, pure-play orthobiologics company headquartered in Hopkinton, Massachusetts, organized through five wholly-owned subsidiaries (Arteriocyte Medical Systems, Isto Technologies II, Progenicare, Progenicare Therapeutics, and Advanced Transfusion Services). The company was founded in 2009 and operates with a headcount in the 11–50 range. Its portfolio spans three product categories: Autologous Therapies (the market-leading Magellan concentration system for PRP, concentrated bone marrow aspirate, and platelet-poor plasma, plus the Precise system and Lightning Needle), Allografts (the Influx family including Fibrant, ProteiOS, SPARC, PLUS, Sponge, and OsseoGEN), and Synthetics (InQu biosynthetic bone graft with demonstrated clinical superiority over iliac crest bone graft).

The company's core technology is centered on point-of-care biologics preparation and tissue processing rather than software or AI. Revenue is generated through one-time product sales of medical devices and biologic tissue products to healthcare providers, with pricing handled via quote requests and direct representative engagement rather than disclosed list pricing. Distribution combines enterprise field sales with regional representatives and a medical distributor network, enabling both direct hospital/surgical center relationships and broader channel-based reach. The company markets primarily to orthopedic and spine surgeons, with secondary segments including medical distributors, hospital value analysis committees, and clinical researchers.

The company maintains an active digital presence through LinkedIn and YouTube and captures leads through HubSpot-powered quote and representative contact forms. No funding rounds, revenue figures, M&A transactions, or regulatory actions are disclosed in the available data, and no AI/ML capabilities, API infrastructure, or software products are described. Operational signals — global customer footprint, continuous product line expansion, and an integrated multi-subsidiary structure — suggest an established but privately opaque operating business.

Short descriptiontext

Isto Biologics (Advanced Biologics) is a privately held, pure-play orthobiologics company developing autologous concentration systems, allograft tissue products, and biosynthetic bone grafts for orthopedic and spine surgeons globally, distributed via direct field sales and medical distributors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCarlsbad, United States
HQ citystring
Carlsbad
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
orthobiologic solutions, autologous concentration systems, allograft bone grafts, biosynthetic bone grafts, regenerative medicine products
Industry4 codes
PRIMARYHLAHAEAG
Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAAAGAH
Cartilage, Bone & Musculoskeletal Regeneration
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAKALAE
Spine (Orthopedic Spine)
SECONDARYHLAKALAC
Orthopedic Surgery (Operative Orthopedics)
NAICS code4 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code3 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
  • Biological Products, (No Disgnostic Substances)2836
Product category
Orthobiologics
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device and Biologics Product Sales
TypeOne Time License
Description

Isto Biologics generates revenue through the sale of its portfolio of orthobiologic products including autologous concentration systems, allograft tissue products, and synthetic bone graft substitutes to healthcare providers, hospitals, and surgical centers.

istobiologics.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 11 records shown
1Magellan
Description

Leading autologous concentration system for creating autologous therapies including Platelet Rich Plasma, Concentrated Bone Marrow Aspirate, and Platelet Poor Plasma

istobiologics.com
+10 more records
Core offering1 text field

Advanced Biologics (operating as Isto Biologics) develops and sells orthobiologic medical products across three categories: Autologous Therapies (including the Magellan Autologous Concentration System, Precise PRP system, and Lightning Needle for PRP and bone marrow aspirate preparation), Allografts (the Influx product family including ProteiOS, Fibrant, SPARC, PLUS, Sponge, and OsseoGEN derived from donor tissue), and Synthetics (the InQu cell-friendly biosynthetic bone graft). The portfolio is sold to surgeons, hospitals, and surgical centers for orthopedic and spinal procedures requiring bone and tissue healing solutions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • InQu biosynthetic bone graft leads to faster bone fusion while outperforming fusion rates of ICBG (Ilium Crest Bone Graft)
Product overview1 text field

Isto Biologics (Advanced Biologics) is a 100% biologics-focused company offering three main product categories: Autologous Therapies, Allografts, and Synthetics. The Autologous Therapies portfolio includes the Magellan Autologous Concentration System (market-leading device for creating PRP, cBMA, and Platelet Poor Plasma), Precise (for Leukocyte Rich/Leukocyte Poor PRP), and Lightning Needle. The Allografts portfolio centers on the Influx family of products derived from donor tissue, including ProteiOS (protein blend), Fibrant (cortical fiber), SPARC (next generation), PLUS, Sponge, and OsseoGEN. The Synthetics portfolio includes InQu, a cell-friendly biosynthetic bone graft with proven clinical efficacy. The company operates through subsidiaries including Arteriocyte Medical Systems, Inc., Isto Technologies II, LLC, Progenicare, LLC, Progenicare Therapeutics, LLC, and Advanced Transfusion Services, LLC.

Product and service11 records
1Magellan Autologous Concentration System
CategoryAutologous Therapy Devices
Description

Market-leading autologous concentration device used to create autologous therapies including Platelet Rich Plasma (PRP), Concentrated Bone Marrow Aspirate (cBMA), and Platelet Poor Plasma (PPP). Sold to surgeons, physicians, hospitals, and surgical centers for use in orthopedic and spine procedures.

2Precise PRP System
CategoryAutologous Therapy Devices
Description

Newest addition to the Autologous Therapies line providing precision targeting options to create Leukocyte Rich and Leukocyte Poor PRP. Used by surgeons and physicians performing autologous procedures.

3Lightning Needle
CategoryAutologous Therapy Devices
Description

Needle technology for autologous therapy procedures including bone marrow aspiration. Sold to surgeons and physicians performing autologous cell-based procedures.

4Influx Allograft Product Line
CategoryAllograft Bone Grafts
Description

Advanced allograft product line derived from donor tissue, setting the standard for bone grafting solutions. Used by surgeons and hospitals for bone grafting and spinal fusion procedures.

5Influx Fibrant
CategoryAllograft Bone Grafts
Description

Breakthrough cortical fiber allograft offering enhanced structural properties for bone grafting procedures. Used by surgeons performing bone grafting and fusion surgeries.

6Influx ProteiOS
CategoryAllograft Bone Grafts
Description

Blend of allograft-derived proteins for bone grafting applications. Used by surgeons and physicians for orthopedic bone repair procedures.

7Influx SPARC
CategoryAllograft Bone Grafts
Description

Next generation allograft offering advanced properties for surgical bone repair and fusion procedures. Sold to surgeons and hospitals performing spinal and orthopedic fusion.

8Influx PLUS
CategoryAllograft Bone Grafts
Description

Enhanced allograft product within the Influx family offering additional capabilities for bone grafting procedures. Used by surgeons for bone repair and fusion surgeries.

9Influx Sponge
CategoryAllograft Bone Grafts
Description

Sponge-form allograft product designed for specific surgical applications requiring conformable grafting material. Sold to surgeons for bone grafting applications.

10OsseoGEN
CategoryAllograft Bone Grafts
Description

Allograft product in the Influx family for bone generation applications. Used by surgeons and physicians for orthopedic bone repair procedures.

11InQu Biosynthetic Bone Graft
CategorySynthetic Bone Grafts
Description

Cell-friendly biosynthetic bone graft with proven clinical efficacy leading to faster bone fusion while outperforming the fusion rates of ICBG (Iliac Crest Bone Graft). Sold to surgeons, hospitals, and surgical centers for bone grafting and fusion procedures.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Pure-play orthobiologics company offering bone graft substitutes (including SIGNAFUSE) and joint preservation therapies. Closely comparable business model to Isto as a focused orthobiologics specialist serving surgeons and hospitals.

TypeBroad incumbent
Description

Diversified medical device company with orthobiologic and regenerative tissue products used in spine, orthopedic, and neurosurgical procedures. Overlaps with Isto's allograft and regenerative medicine portfolio.

TypeBroad incumbent
Description

Diversified medtech major with Infuse Bone Graft / rhBMP-2 — one of the most established orthobiologic and bone graft substitute franchises. Competes directly with Isto's Influx and InQu lines in spinal fusion, and far larger sales coverage to hospitals.

TypeBroad incumbent
Description

Major orthopedic medtech with a biologics portfolio including bone graft substitutes and regenerative solutions used in joint reconstruction and spine. Competes with Isto across autologous, allograft, and synthetic categories at scale.

TypeDirect peer
Description

Orthopedic biologics franchise now part of Stryker, with allograft and synthetic bone graft offerings (e.g., AUGMENT). Direct competitor to Isto's allograft and synthetic bone graft portfolio in extremities and orthopedic reconstruction.

TypeDirect peer
Description

Spine-focused medtech with orthobiologic offerings (e.g., AttraX, Osteocel) used in spinal fusion procedures. Highly comparable to Isto's spine-focused bone graft substitute and allograft portfolio.

TypeBroad incumbent
Description

Orthopedic and spine medtech division of J&J with a broad biologics portfolio including allograft and synthetic bone graft products. Competes with Isto's allograft and synthetic categories with deep hospital enterprise coverage.

TypeBroad incumbent
Description

Large orthopedic and spine medtech with biologic and bone graft substitute offerings (including through its Wright Medical acquisition). Competes with Isto across allograft and synthetic bone graft categories with substantially larger sales and R&D scale.

9Bone Biologics
TypeEmerging player
Description

Emerging orthobiologics company developing bone graft substitutes for spinal fusion. Comparable in focus area (bone graft substitutes for spine) but smaller and earlier-stage than Isto, with narrower commercial reach.

TypeDirect peer
Description

Orthopedic medtech specializing in sports medicine and autologous biologic therapies, including PRP and bone marrow concentration systems. Directly comparable to Isto's Magellan autologous concentration franchise and surgical needle offerings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Advanced Biologics

Orthobiologicsadvancedbiologics.com

Isto Biologics (Advanced Biologics) is a privately held, pure-play orthobiologics company developing autologous concentration systems, allograft tissue products, and biosynthetic bone grafts for orthopedic and spine surgeons globally, distributed via direct field sales and medical distributors.

What Advanced Biologics does

Advanced Biologics operates as Isto Biologics, a privately held, pure-play orthobiologics company headquartered in Hopkinton, Massachusetts, organized through five wholly-owned subsidiaries (Arteriocyte Medical Systems, Isto Technologies II, Progenicare, Progenicare Therapeutics, and Advanced Transfusion Services). The company was founded in 2009 and operates with a headcount in the 11–50 range. Its portfolio spans three product categories: Autologous Therapies (the market-leading Magellan concentration system for PRP, concentrated bone marrow aspirate, and platelet-poor plasma, plus the Precise system and Lightning Needle), Allografts (the Influx family including Fibrant, ProteiOS, SPARC, PLUS, Sponge, and OsseoGEN), and Synthetics (InQu biosynthetic bone graft with demonstrated clinical superiority over iliac crest bone graft).

The company's core technology is centered on point-of-care biologics preparation and tissue processing rather than software or AI. Revenue is generated through one-time product sales of medical devices and biologic tissue products to healthcare providers, with pricing handled via quote requests and direct representative engagement rather than disclosed list pricing. Distribution combines enterprise field sales with regional representatives and a medical distributor network, enabling both direct hospital/surgical center relationships and broader channel-based reach. The company markets primarily to orthopedic and spine surgeons, with secondary segments including medical distributors, hospital value analysis committees, and clinical researchers.

The company maintains an active digital presence through LinkedIn and YouTube and captures leads through HubSpot-powered quote and representative contact forms. No funding rounds, revenue figures, M&A transactions, or regulatory actions are disclosed in the available data, and no AI/ML capabilities, API infrastructure, or software products are described. Operational signals — global customer footprint, continuous product line expansion, and an integrated multi-subsidiary structure — suggest an established but privately opaque operating business.

Advanced Biologics firmographics

Firmographics
Name
Advanced Biologics
Legal name
Isto Biologics
Website
https://advancedbiologics.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
11–50 employees
Short description
Isto Biologics (Advanced Biologics) is a privately held, pure-play orthobiologics company developing autologous concentration systems, allograft tissue products, and biosynthetic bone grafts for orthopedic and spine surgeons globally, distributed via direct field sales and medical distributors.
Ownership category
akta.pro rank

Advanced Biologics industry classification

Industry
Product category
Orthobiologics
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAHAEAG
Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAAAGAH
Cartilage, Bone & Musculoskeletal Regeneration
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAKALAE
Spine (Orthopedic Spine)
SECONDARYHLAKALAC
Orthopedic Surgery (Operative Orthopedics)

Keywords

  • Orthobiologic solutions
  • Autologous concentration systems
  • Allograft bone grafts
  • Biosynthetic bone grafts
  • Regenerative medicine products

Where Advanced Biologics is headquartered

Location

Headquarters

HQ city
Carlsbad
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Advanced Biologics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Medical Device and Biologics Product Sales: Isto Biologics generates revenue through the sale of its portfolio of orthobiologic products including autologous concentration systems, allograft tissue products, and synthetic bone graft substitutes to healthcare providers, hospitals, and surgical centers.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Advanced Biologics product offering

Product offering

Core offering

Advanced Biologics (operating as Isto Biologics) develops and sells orthobiologic medical products across three categories: Autologous Therapies (including the Magellan Autologous Concentration System, Precise PRP system, and Lightning Needle for PRP and bone marrow aspirate preparation), Allografts (the Influx product family including ProteiOS, Fibrant, SPARC, PLUS, Sponge, and OsseoGEN derived from donor tissue), and Synthetics (the InQu cell-friendly biosynthetic bone graft). The portfolio is sold to surgeons, hospitals, and surgical centers for orthopedic and spinal procedures requiring bone and tissue healing solutions.

Product overview

Isto Biologics (Advanced Biologics) is a 100% biologics-focused company offering three main product categories: Autologous Therapies, Allografts, and Synthetics. The Autologous Therapies portfolio includes the Magellan Autologous Concentration System (market-leading device for creating PRP, cBMA, and Platelet Poor Plasma), Precise (for Leukocyte Rich/Leukocyte Poor PRP), and Lightning Needle. The Allografts portfolio centers on the Influx family of products derived from donor tissue, including ProteiOS (protein blend), Fibrant (cortical fiber), SPARC (next generation), PLUS, Sponge, and OsseoGEN. The Synthetics portfolio includes InQu, a cell-friendly biosynthetic bone graft with proven clinical efficacy. The company operates through subsidiaries including Arteriocyte Medical Systems, Inc., Isto Technologies II, LLC, Progenicare, LLC, Progenicare Therapeutics, LLC, and Advanced Transfusion Services, LLC.

Differentiator

Problem solved

Functional benefit

Brands

  • Magellan: Leading autologous concentration system for creating autologous therapies including Platelet Rich Plasma, Concentrated Bone Marrow Aspirate, and Platelet Poor Plasma
  • Precise
  • Lightning Needle
  • Influx
  • Influx Fibrant
  • Influx ProteiOS
  • Influx SPARC
  • Influx PLUS
  • Influx Sponge
  • OsseoGEN
  • InQu

Products and services

  • Magellan Autologous Concentration System Market-leading autologous concentration device used to create autologous therapies including Platelet Rich Plasma (PRP), Concentrated Bone Marrow Aspirate (cBMA), and Platelet Poor Plasma (PPP). Sold to surgeons, physicians, hospitals, and surgical centers for use in orthopedic and spine procedures.
  • Precise PRP System Newest addition to the Autologous Therapies line providing precision targeting options to create Leukocyte Rich and Leukocyte Poor PRP. Used by surgeons and physicians performing autologous procedures.
  • Lightning Needle Needle technology for autologous therapy procedures including bone marrow aspiration. Sold to surgeons and physicians performing autologous cell-based procedures.
  • Influx Allograft Product Line Advanced allograft product line derived from donor tissue, setting the standard for bone grafting solutions. Used by surgeons and hospitals for bone grafting and spinal fusion procedures.
  • Influx Fibrant Breakthrough cortical fiber allograft offering enhanced structural properties for bone grafting procedures. Used by surgeons performing bone grafting and fusion surgeries.
  • Influx ProteiOS Blend of allograft-derived proteins for bone grafting applications. Used by surgeons and physicians for orthopedic bone repair procedures.
  • Influx SPARC Next generation allograft offering advanced properties for surgical bone repair and fusion procedures. Sold to surgeons and hospitals performing spinal and orthopedic fusion.
  • Influx PLUS Enhanced allograft product within the Influx family offering additional capabilities for bone grafting procedures. Used by surgeons for bone repair and fusion surgeries.
  • Influx Sponge Sponge-form allograft product designed for specific surgical applications requiring conformable grafting material. Sold to surgeons for bone grafting applications.
  • OsseoGEN Allograft product in the Influx family for bone generation applications. Used by surgeons and physicians for orthopedic bone repair procedures.
  • InQu Biosynthetic Bone Graft Cell-friendly biosynthetic bone graft with proven clinical efficacy leading to faster bone fusion while outperforming the fusion rates of ICBG (Iliac Crest Bone Graft). Sold to surgeons, hospitals, and surgical centers for bone grafting and fusion procedures.

Quantifiable outcome

  • InQu biosynthetic bone graft leads to faster bone fusion while outperforming fusion rates of ICBG (Ilium Crest Bone Graft)

Companies that use Advanced Biologics

Customer profile

Segments4 records

Ideal customer profiles3 records

Advanced Biologics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Advanced Biologics partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Advanced Biologics competitors and assessment

Company assessment

Direct peers

  • Bioventus: Pure-play orthobiologics company offering bone graft substitutes (including SIGNAFUSE) and joint preservation therapies. Closely comparable business model to Isto as a focused orthobiologics specialist serving surgeons and hospitals.
  • Wright Medical (Stryker Trauma & Extremities): Orthopedic biologics franchise now part of Stryker, with allograft and synthetic bone graft offerings (e.g., AUGMENT). Direct competitor to Isto's allograft and synthetic bone graft portfolio in extremities and orthopedic reconstruction.
  • NuVasive / Globus Medical: Spine-focused medtech with orthobiologic offerings (e.g., AttraX, Osteocel) used in spinal fusion procedures. Highly comparable to Isto's spine-focused bone graft substitute and allograft portfolio.
  • Arthrex: Orthopedic medtech specializing in sports medicine and autologous biologic therapies, including PRP and bone marrow concentration systems. Directly comparable to Isto's Magellan autologous concentration franchise and surgical needle offerings.

Broad incumbents

  • Integra LifeSciences: Diversified medical device company with orthobiologic and regenerative tissue products used in spine, orthopedic, and neurosurgical procedures. Overlaps with Isto's allograft and regenerative medicine portfolio.
  • Medtronic: Diversified medtech major with Infuse Bone Graft / rhBMP-2 — one of the most established orthobiologic and bone graft substitute franchises. Competes directly with Isto's Influx and InQu lines in spinal fusion, and far larger sales coverage to hospitals.
  • Zimmer Biomet: Major orthopedic medtech with a biologics portfolio including bone graft substitutes and regenerative solutions used in joint reconstruction and spine. Competes with Isto across autologous, allograft, and synthetic categories at scale.
  • DePuy Synthes (Johnson & Johnson): Orthopedic and spine medtech division of J&J with a broad biologics portfolio including allograft and synthetic bone graft products. Competes with Isto's allograft and synthetic categories with deep hospital enterprise coverage.
  • Stryker: Large orthopedic and spine medtech with biologic and bone graft substitute offerings (including through its Wright Medical acquisition). Competes with Isto across allograft and synthetic bone graft categories with substantially larger sales and R&D scale.

Emerging players

  • Bone Biologics: Emerging orthobiologics company developing bone graft substitutes for spinal fusion. Comparable in focus area (bone graft substitutes for spine) but smaller and earlier-stage than Isto, with narrower commercial reach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Advanced Biologics social profiles

Digital presence

Advanced Biologics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Advanced Biologics leadership team

Management profile

Number of profiles

Profiles1 record

Advanced Biologics subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Advanced Biologics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Advanced Biologics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Advanced Biologics

What does Advanced Biologics do?

Advanced Biologics (operating as Isto Biologics) develops and sells orthobiologic medical products across three categories: Autologous Therapies (including the Magellan Autologous Concentration System, Precise PRP system, and Lightning Needle for PRP and bone marrow aspirate preparation), Allografts (the Influx product family including ProteiOS, Fibrant, SPARC, PLUS, Sponge, and OsseoGEN derived from donor tissue), and Synthetics (the InQu cell-friendly biosynthetic bone graft). The portfolio is sold to surgeons, hospitals, and surgical centers for orthopedic and spinal procedures requiring bone and tissue healing solutions.

Is Advanced Biologics a public or private company?

Advanced Biologics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Advanced Biologics founded?

Advanced Biologics was founded in 2009. It employs 11 to 50 people.

Where is Advanced Biologics based?

Advanced Biologics is headquartered in Carlsbad, United States, in the North America region.

How does Advanced Biologics make money?

One revenue line is on record: medical Device and Biologics Product Sales.

Who are Advanced Biologics's main competitors?

Direct peers on record are Bioventus, Wright Medical (Stryker Trauma & Extremities), NuVasive / Globus Medical and Arthrex. Broad incumbents are Integra LifeSciences, Medtronic, Zimmer Biomet, DePuy Synthes (Johnson & Johnson) and Stryker. Bone Biologics is listed as an emerging player.

Does Advanced Biologics have an API?

No public API is recorded for Advanced Biologics.

What industry is Advanced Biologics in?

Advanced Biologics's product category is Orthobiologics. Its primary akta.pro industry code is HLAHAEAG, Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM), with a secondary code of HLAAAGAH, Cartilage, Bone & Musculoskeletal Regeneration. Its NAICS code is 325414 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals